FGL1 and neoplasm: A549, H226, and LLC cell lines were used for subcutaneous tumor-bearing nude mice, and shFGL1_AAV9 was used for intratumoral injection when the Tumor volume reached 150–200 mm3 to achieve FGL1 knockdown in vivo.